1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61C2733DB8DB6218C85257CEE006C6D01
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/1C2733DB8DB6218C85257CEE006C6D01!OpenDocument
18
19OpenDocument
203.80.128.196
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Managed Care Managed Care Organizations and Winning Practices

Document Excerpt: iPad Utilization in Managed Markets: Security and Measuring Effectiveness

DB Image

ID: MD-415


Features:

14 Info Graphics

17 Data Graphics

130+ Metrics


Pages/Slides: 4


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click
"Download Free Excerpt".

To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5311 "iPad Utilization in Managed Markets: Security and Measuring Effectiveness."

Industries Profiled:
Pharmaceutical; Biotech; Academic; Health Care; Electronics; Biopharmaceutical; Clinical Research; Laboratories; Chemical


Companies Profiled:
Janssen; Abbvie; Boehringer Ingelheim; Rimedio; Teva Pharmaceutical Industries Ltd; Abbott Nutrition; Lung LLC; Panasonic; Novo Nordisk; Biogen Idec; Sanofi; UCB Pharma; Astellas; Genentech


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.